The mark consists of stylized "DISCOVERING" "DEVELOPING" "DELIVERING HOPE" with a dot on either side of "DEVELOPING".
Mark For: DISCOVERING DEVELOPING DELIVERING HOPE® trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of stylized "DISCOVERING" "DEVELOPING" "DELIVERING HOPE" with a dot on either side of "DEVELOPING".
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88186713 |
Registration Number | 6337607 |
Mark Literal Elements | DISCOVERING DEVELOPING DELIVERING HOPE |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2021-01-14 |
Basis | 44(e) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | No |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Howard M. Gitten |
Attorney Docket Number | 40836-6030US |
Law Office Assigned | L40 |
Employee Name | MARTIN, CHRISTINE C |
2018-11-08 | Application Filed |
2019-08-02 | Location: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED |
2019-08-02 | Status: Live/Pending |
2019-08-02 | Transaction Date |
2020-03-26 | Trademark Registered |
2021-01-14 | Location: PUBLICATION AND ISSUE SECTION |
2021-02-16 | Published |
2021-02-16 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
2021-05-04 | Trademark Registered |
Party: | ![]() |
Address | C & H Building, 3rd Floor, 35 Teheran-ro 87-Gil, Gangnam-Gu Seoul KOREA, REPUBLIC OF 06167 |
Legal Entity Type | Limited Company (ltd.) |
Legal Entity State | KOREA, REPUBLIC OF |
![]() | JPEG | 2018-11-08 |
![]() | MULTI | 2018-11-08 |
![]() | APPLICATION/XML | 2018-11-28 |
![]() | APPLICATION/XML | 2019-01-23 |
![]() | MULTI | 2019-01-24 |
![]() | MULTI | 2019-07-24 |
![]() | MULTI | 2019-08-01 |
![]() | XML | 2019-08-02 |
![]() | XML | 2020-02-10 |
![]() | MULTI | 2020-06-12 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2020-06-17 |
![]() | MULTI | 2020-06-17 |
![]() | XML | 2020-06-30 |
![]() | APPLICATION/XML | 2020-12-28 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2020-12-29 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2021-01-05 |
![]() | XML | 2021-01-27 |
![]() | XML | 2021-01-27 |
![]() | APPLICATION/XML | 2021-02-16 |
26.01.21 | Circles that are totally or partially shaded. |
260113 | Circles, two (not concentric); Two circles |
260121 | Circles that are totally or partially shaded. |
IC 041. US 100 101 107. G & S: Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues
IC 042. US 100 101. G & S: Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine
IC 044. US 100 101. G & S: Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
International Codes: | 41 |
U.S. Codes: | 100,101,107 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2021-02-16 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-02-16 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-01-27 | |
ELECTRONIC RECORD REVIEW COMPLETE | 2021-01-14 | 79148 |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2021-01-08 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-01-04 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-12-28 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-12-28 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-12-28 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-30 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-06-30 | 85324 |
NON-FINAL ACTION E-MAILED | 2020-06-30 | 6325 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-06-16 | 69712 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-06-16 | 69712 |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2020-06-12 | |
SUSPENSION INQUIRY WRITTEN | 2020-02-10 | 85324 |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2020-02-10 | |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2020-02-10 | 69712 |
INQUIRY TO SUSPENSION E-MAILED | 2020-02-10 | |
SUSPENSION LETTER WRITTEN | 2019-08-02 | 85324 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-08-02 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2019-08-02 | 6332 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-07-31 | 69712 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-07-31 | 69712 |
ASSIGNED TO LIE | 2019-07-29 | 69712 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-07-24 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-01-24 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-01-24 | 85324 |
NON-FINAL ACTION E-MAILED | 2019-01-24 | 6325 |
ASSIGNED TO EXAMINER | 2019-01-22 | 85324 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-11-28 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-27 | |
NEW APPLICATION ENTERED IN TRAM | 2018-11-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.